Product Description
Follistatin binds to myostatin with high affinity, preventing its inhibitory effect on skeletal muscle growth, making it a key tool for studying muscle hypertrophy and sarcopenia models.
Beyond muscle growth, Follistatin promotes cell proliferation, tissue repair, and recovery in various organ systems, including liver, heart, and skeletal muscle.
By binding activin, Follistatin regulates FSH (follicle-stimulating hormone) secretion, making it useful in reproductive biology studies.
Research suggests Follistatin can reduce fibrosis and improve metabolic outcomes, supporting studies in liver disease, obesity, and insulin resistance.
Available as a highly purified, biologically active protein suitable for in vitro and in vivo experimental applications.
| Parameter | Description |
| CAS Number | 80449-31-6 |
| Product Name | Follistatin |
| Molecular Formula | C₁₈₁H₂₉₇N₅₅O₅₁S₁₀ |
| Molecular Weight | ~25,000–28,000 Da (depending on glycosylation) |
| Peptide Length | 344 amino acids (glycoprotein) |
| Appearance | White to off-white lyophilized powder |
| Storage | –20°C, protected from light and moisture |
| Specification | Option |
| Purity | ≥95% (SDS-PAGE / HPLC) |
| Form | Lyophilized protein powder |
| Vial Sizes | 1 mg, 5 mg, 10 mg (custom packaging available) |
| Packaging | Sterile sealed vials, moisture-resistant, temperature-controlled |
| Shelf Life | 12–24 months under recommended storage conditions |
1. Muscle Growth & Myostatin Research: Used in studies targeting skeletal muscle hypertrophy, muscle wasting disorders, and sarcopenia.
2. Tissue Regeneration & Repair Studies: Supports research in liver regeneration, cardiac repair, and skeletal muscle recovery.
3. Reproductive Biology Research: Investigates FSH regulation, activin modulation, and reproductive hormone pathways.
4. Metabolic Disease & Anti-Fibrotic Research: Explores obesity, insulin resistance, and fibrosis models in preclinical studies.
5. Peptide Therapeutic Development: Serves as a template for designing myostatin inhibitors and regenerative medicine therapeutics.